NYSE: HNGE

Hinge Health (HNGE) Stock Analysis & Forecast

Nov 13 close

$115.39−5.60 (−4.6%)

Gekko Brief

AI summaryNov 9 close

Hinge Health moves higher this week on the back of third-quarter results reported 2 November, with revenue growth of 52% year over year and an earnings beat against estimate, alongside a raised full-year outlook. The earnings call cited higher member engagement, client additions, and improved operating leverage, with gross margin reaching 88% and operating income hitting $77M at a 33% margin. A note on rising earnings estimate revisions also points to continued near-term interest in the shares.

The stock closes at $122.19, up 5.6%, sitting above both its 50-day average of $101.53 and its 200-day average of $69.32, with the shorter average above the longer one, consistent with an established uptrend. The GekkoIndex reads 46.8, placing HNGE in the Neutral zone, while the price sits 7.9% above the Gekko Fair Value of $113.2.

The next earnings date falls on 9 February 2027, 91 days out, placing it beyond a typical 20-trading-day holding window. No insider, Congress, or unusual options activity shows up in the current windows, leaving smart-money signals quiet for now. Analyst coverage remains heavily tilted toward buy ratings among 11 firms, with a consensus target implying further upside from current levels. The gap to Gekko Fair Value, along with the historically wide average reaction of 12.4% around past reports, bears watching.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Hinge Health price vs fair value

$116.46$115.39Nov ’25May ’26Nov ’26
Close $115.39200-day averageGekko Fair Value $116.46

Hinge Health quick facts

Market cap
$9.38B
P/E ratio
32.8
Forward P/E
40.5
EPS, TTM
$3.69
Revenue, TTM
$800.8M
Profit margin
21%
Dividend yield
—
Beta
—
Volume
1.29M avg 1.83M
1-year return
+172.6%
Typical daily move
±5.1%
Typical 20-day move
±13.3%
50-day average
$103.85
200-day average
$70.95
Next earnings
Feb 9 after close
Shares outstanding
68.49M
52-week range
$30.08$126.40

Hinge Health swing-trade checklist

Hinge Health scores 2 supportive, 2 mixed and 0 headwinds across the 4 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive2 mixed0 headwinds

  • Trendsupportive

    Above 50 and 200-day

    Close $115.39 is above the 50-day ($103.85) and 200-day ($70.95) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    53.5, Neutral

    Reading 53.5 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuemixed

    0.9% below

    Price is within 5% of Gekko Fair Value (0.9% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 86 days

    Next report Feb 9, 2027, 86 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalityno data

    No data

    Not enough years of history for a seasonal read.

A description of current data, not a recommendation. How this page works

Hinge Health stock chart and price history

Hinge Health closed at $115.39 on Nov 13, 2026, +172.6% over the past year, inside a 52-week range of $30.08 to $126.40.

Close50-day average200-day averageVolume
Hinge Health share price, past year, with 50-day and 200-day moving averages and volume$40$60$80$100DecJan 2026FebMarAprMayJunJulAugSepOctNov115.39

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+9.9%
3 months
+31.3%
6 months
+111.7%
1 year
+172.6%
The full HNGE chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HNGE in Gekko

Follow Hinge Health through every session

Put HNGE on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track HNGE in GekkoFree for 7 days. No credit card required.

About Hinge Health

Hinge Health builds software aimed at musculoskeletal and joint health, giving people tools to address everyday joint and muscle issues, sudden injuries, ongoing chronic pain, and recovery after surgery. It is best known for offering a single platform that follows a patient through this whole range of musculoskeletal needs rather than treating each issue separately.

Beyond the clinical side of its platform, Hinge Health also handles administrative and operational support tasks tied to delivering this care, rounding out the service it provides.

Hinge Health was founded in 2012 and is headquartered in San Francisco, California. Its shares are listed on the NYSE under the ticker HNGE.

Listed
NYSE
Sector
Technology services
Industry
Packaged software
Website
hingehealth.com

Hinge Health GekkoIndex: the smart money zone

Hinge Health’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 53.5, in the Neutral zone, up 5 points over five sessions.

010053.5Neutral

Up 5 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying19+3.7%+9.5%+22.5%+8.1%
Accumulation74+2.8%+3.6%+6.9%+20.2%
Neutral (current zone)215+0.9%+2.7%+5.5%+16.3%
Distribution51+4.3%+7.3%+13.4%+26.4%
Selling4Too few readings yet

Average HNGE share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the HNGE price, zone by zone.Track HNGE in Gekko

Is Hinge Health stock overvalued? Gekko Fair Value

Hinge Health trades 0.9% below Gekko Fair Value of $116.46, so the shares are about fair value on Gekko’s estimate.

Gekko’s own estimate of what Hinge Health shares are worth, recalculated every trading day.

$116.46

Gekko Fair Value, Nov 14, 2026

0.9% below fair value · About fair value

At the end of Aug 2026 the price was 6.1% below the estimate.

Gekko Fair ValueShare price, month end
$116$115Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open HNGE in Gekko

Hinge Health insider and Congress trading

No open-market insider purchases were filed for Hinge Health, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for HNGE in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every HNGE insider filing, plotted on the chart in Gekko.Open HNGE in Gekko

Congress trades last 90 days

No trades in HNGE were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for HNGE, plotted on the chart in Gekko.Open HNGE in Gekko

Buybacks

Hinge Health has been buying back its own shares.

Latest authorization
$300.0M, Aug 4, 2026
Bought back, quarter ended Sep 30, 2026
$25.89M
As a share of market cap
0.28%
Trailing four quarters
$222.4M

From company filings.

Hedge funds and billionaires quarter ended Sep 30

2of the funds Gekko tracks hold HNGE.

0added0opened2trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko

Hinge Health earnings: next date and track record

Hinge Health reports on Feb 9, 2027, after the close (86 days away), and beat the EPS estimate in 7 of its last 7 reports.

7 of 7reports beat the EPS estimate
±12.4%average move across the report
5 of 6reports followed by a gain

Share-price move across each report

+25.6%Aug ’25−9.8%Nov ’25+20.5%Feb ’26+12.2%May ’26+4.0%Aug ’26+2.2%Nov ’26

Last earnings call, Nov 2, 2026 AI summary

What they said
Hinge Health reported Q3 2026 revenue of $235M, up 52% YoY. Gross margin reached 88% (+480bps YoY), operating income hit $77M (33% margin, +1,300bps YoY), and free cash flow margin was 51% at $120M. Last-12-month calculated billings grew 54% to $960M. Early Migraine Care Program data shows 23% reduction in monthly migraine days and 28% shorter attack duration.
Guidance
Management updated guidance following strong Q3 results with continued momentum from H1 2026 carrying forward. Specific updated targets to be detailed by CFO James Budge during the call.
ReportedEPSSurpriseRevenueSurpriseMove
Nov 2, 2026$0.71
est $0.58
+23.3%$235.0M
est $224.8M
+4.5%+2.2%
Aug 4, 2026$0.66
est $0.28
+135.7%$212.8M
est $201.5M
+5.6%+4.0%
May 5, 2026$0.45
est $0.40
+12.5%$182.3M
est $172.2M
+5.9%+12.2%
Feb 10, 2026$0.49
est $0.43
+14.0%$170.7M
est $156.7M
+9.0%+20.5%
Nov 4, 2025$0.34
est $0.24
+41.7%$154.2M
est $156.8M
−1.6%−9.8%
Aug 5, 2025$0.67
est $0.09
+644.4%$139.1M
est $132.4M
+5.1%+25.6%
May 5, 2025$0.21
est $0.09
+147.0%$123.8M
est $125.4M
−1.2%—
Mar 10, 2025$0.35—$117.3M——

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Hinge Health stock forecast and analyst price targets

Analysts’ average 12-month price target for Hinge Health is $135.38, +17.3% from the last close, from 11 firms rating the stock in the last 90 days.

$135.38consensus 12-month target, +17.3% from the last close
Low $90High $140
Buy10
Hold1
Sell0

Each firm’s latest rating in the last 90 days: 11 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 10Stifel NicolausBuy, maintained$135+17.0%
Nov 3Raymond JamesBuy, maintained$138+19.6%
Nov 3Morgan StanleyBuy, maintained$131+13.5%
Nov 3Stifel NicolausBuy, maintained$135+17.0%
Nov 3Canaccord GenuityBuy, maintained$134+16.1%
+5.5%average 20-day move after past Neutral readings
±5.1%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Hinge Health market cap and key statistics

Hinge Health’s market cap is $9.38B, with a P/E ratio of 32.8 and revenue of $800.8M over the last twelve months.

Valuation

Market cap
$9.38B
P/E ratio
32.8
Forward P/E
40.5
EPS, TTM
$3.69
Gekko Fair Value
$116.46

Trading

Volume
1.29M
Avg volume, 20 days
1.83M
52-week high
$126.40
52-week low
$30.08
Shares outstanding
68.49M

Financials

Revenue, TTM
$800.8M
Profit margin
21%
Return on equity
47.6%
Quarterly earnings growth, YoY
−68.4%

Risk and income

Typical daily move
±5.1%
Typical 20-day move
±13.3%

Hinge Health peers

Hinge Health’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
MSFTMicrosoft+0.8%Neutral10.6% above
PLTRPalantir Technologies−2.2%Accumulation8.2% below
ORCLOracle−1.7%Neutral27.9% below
PANWPalo Alto Networks−2.5%Accumulation0.6% above
CRWDCrowdStrike−4.0%Accumulation0.9% above
CRMSalesforce−1.0%Accumulation12.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Packaged software

Hinge Health stock FAQ

What is Hinge Health’s market cap?

Hinge Health’s market cap is $9.38B at the Nov 13, 2026 close of $115.39, with 68.49M shares outstanding. The shares trade on a P/E ratio of 32.8.

What is the Hinge Health stock forecast?

The consensus analyst 12-month price target for Hinge Health is $135.38, +17.3% from the last close. Of the 11 firms that rated the stock in the last 90 days, 10 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Hinge Health stock overvalued or undervalued?

On Gekko’s estimate Hinge Health is about fair value: the Nov 13, 2026 close of $115.39 is 0.9% below Gekko Fair Value of $116.46. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Hinge Health report earnings next?

Hinge Health is expected to report on Feb 9, 2027, after the market closes (86 days away). Analysts expect earnings of $0.74 per share on revenue of $249.2M. Hinge Health beat the earnings estimate in 7 of its last 7 reports, moving 12.4% on average across the report.

What is Hinge Health’s 52-week high and low?

Hinge Health’s 52-week high is $126.40 and its 52-week low is $30.08; it closed at $115.39 on Nov 13, 2026, +172.6% over the past year.

Is Hinge Health stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 4 items with data read as supportive (trend and earnings risk), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Hinge Health the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.